Hartman Institute for Therapeutic Organ Regeneration

Male germ cells support long-term propagation of Zika virus.

TitleMale germ cells support long-term propagation of Zika virus.
Publication TypeJournal Article
Year of Publication2018
AuthorsRobinson CL, Chong ACN, Ashbrook AW, Jeng G, Jin J, Chen H, Tang EI, Martin LA, Kim RS, Kenyon RM, Do E, Luna JM, Saeed M, Zeltser L, Ralph H, Dudley VL, Goldstein M, Rice CM, C Cheng Y, Seandel M, Chen S
JournalNat Commun
Volume9
Issue1
Pagination2090
Date Published2018 May 29
ISSN2041-1723
KeywordsAnimals, Antigens, Antiviral Agents, Berberine, Cell Proliferation, Cells, Cultured, Chlorocebus aethiops, Cytoskeletal Proteins, Dengue Virus, Humans, Interferon Type I, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Receptor, Interferon alpha-beta, RNA, Viral, Sexually Transmitted Diseases, Viral, Spermatozoa, Testis, Vero Cells, Virus Replication, Yellow fever virus, Zika Virus, Zika Virus Infection
Abstract

<p>Evidence of male-to-female sexual transmission of Zika virus (ZIKV) and viral RNA in semen and sperm months after infection supports a potential role for testicular cells in ZIKV propagation. Here, we demonstrate that germ cells (GCs) are most susceptible to ZIKV. We found that only GCs infected by ZIKV, but not those infected by dengue virus and yellow fever virus, produce high levels of infectious virus. This observation coincides with decreased expression of interferon-stimulated gene Ifi44l in ZIKV-infected GCs, and overexpression of Ifi44l results in reduced ZIKV production. Using primary human testicular tissue, we demonstrate that human GCs are also permissive for ZIKV infection and production. Finally, we identified berberine chloride as a potent inhibitor of ZIKV infection in both murine and human testes. Together, these studies identify a potential cellular source for propagation of ZIKV in testes and a candidate drug for preventing sexual transmission of ZIKV.</p>

DOI10.1038/s41467-018-04444-w
Alternate JournalNat Commun
PubMed ID29844387
PubMed Central IDPMC5974187
Grant ListDP2 DK098093 / DK / NIDDK NIH HHS / United States
DP2 HD080352 / HD / NICHD NIH HHS / United States
R01 HD056034 / HD / NICHD NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065